Cargando…
Cysteine-Altering NOTCH3 Variants Are a Risk Factor for Stroke in the Elderly Population
Cysteine altering NOTCH3 variants, which have previously been exclusively associated with the rare hereditary small vessel disease cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, have a population frequency of 1:300 worldwide. Using a large population data...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678653/ https://www.ncbi.nlm.nih.gov/pubmed/33161844 http://dx.doi.org/10.1161/STROKEAHA.120.030343 |
_version_ | 1783612201854042112 |
---|---|
author | Hack, Remco J. Rutten, Julie W. Person, Thomas N. Li, Jiang Khan, Ayesha Griessenauer, Christoph J. Abedi, Vida Lesnik Oberstein, Saskia A.J. Zand, Ramin |
author_facet | Hack, Remco J. Rutten, Julie W. Person, Thomas N. Li, Jiang Khan, Ayesha Griessenauer, Christoph J. Abedi, Vida Lesnik Oberstein, Saskia A.J. Zand, Ramin |
author_sort | Hack, Remco J. |
collection | PubMed |
description | Cysteine altering NOTCH3 variants, which have previously been exclusively associated with the rare hereditary small vessel disease cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, have a population frequency of 1:300 worldwide. Using a large population database, and taking genotype as a starting point, we aimed to determine whether individuals harboring a NOTCH3 cysteine altering variant have a higher load of small vessel disease markers on brain magnetic resonance imaging than controls, as well as a higher risk of stroke and cognitive impairment. METHODS: A cross-sectional study using integrated clinical, neuroimaging, and whole-exome sequencing data of 92 456 participants from the Geisinger DiscovEHR initiative cohort. The case group consisted of individuals harboring a NOTCH3 cysteine altering variant (n=118). The control group consisted of randomly selected age- and sex-matched individuals who did not have any nonsynonymous variants in NOTCH3 (n=184). Medical records including brain magnetic resonance imagings were evaluated for clinical and neuroimaging findings associated with small vessel disease. Group comparisons were done using Fisher exact test and ordinal logistic regression models. Risk of stroke was assessed using Cox regression. RESULTS: Of the 118 cases, 39.0% were men, mean age 58.1±16.9 years; 12.6% had a history of stroke, compared with 4.9% of controls. The risk of stroke was significantly increased after age 65 years (hazard ratio, 6.0 [95% CI, 1.4–26.3]). Dementia, mild cognitive impairment, migraine with aura and depression were equally prevalent in cases and controls. Twenty-nine cases (25%) and 45 controls (24%) had an available brain magnetic resonance imaging. After age 65 years, cases had a higher white matter lesion burden and more lacunes. A severe small vessel disease phenotype compatible with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy was rarely seen. CONCLUSIONS: Cysteine altering NOTCH3 variants are an important contributor to the risk of stroke, lacunes, and white matter hyperintensities in the elderly population. |
format | Online Article Text |
id | pubmed-7678653 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-76786532020-11-23 Cysteine-Altering NOTCH3 Variants Are a Risk Factor for Stroke in the Elderly Population Hack, Remco J. Rutten, Julie W. Person, Thomas N. Li, Jiang Khan, Ayesha Griessenauer, Christoph J. Abedi, Vida Lesnik Oberstein, Saskia A.J. Zand, Ramin Stroke Original Contributions Cysteine altering NOTCH3 variants, which have previously been exclusively associated with the rare hereditary small vessel disease cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, have a population frequency of 1:300 worldwide. Using a large population database, and taking genotype as a starting point, we aimed to determine whether individuals harboring a NOTCH3 cysteine altering variant have a higher load of small vessel disease markers on brain magnetic resonance imaging than controls, as well as a higher risk of stroke and cognitive impairment. METHODS: A cross-sectional study using integrated clinical, neuroimaging, and whole-exome sequencing data of 92 456 participants from the Geisinger DiscovEHR initiative cohort. The case group consisted of individuals harboring a NOTCH3 cysteine altering variant (n=118). The control group consisted of randomly selected age- and sex-matched individuals who did not have any nonsynonymous variants in NOTCH3 (n=184). Medical records including brain magnetic resonance imagings were evaluated for clinical and neuroimaging findings associated with small vessel disease. Group comparisons were done using Fisher exact test and ordinal logistic regression models. Risk of stroke was assessed using Cox regression. RESULTS: Of the 118 cases, 39.0% were men, mean age 58.1±16.9 years; 12.6% had a history of stroke, compared with 4.9% of controls. The risk of stroke was significantly increased after age 65 years (hazard ratio, 6.0 [95% CI, 1.4–26.3]). Dementia, mild cognitive impairment, migraine with aura and depression were equally prevalent in cases and controls. Twenty-nine cases (25%) and 45 controls (24%) had an available brain magnetic resonance imaging. After age 65 years, cases had a higher white matter lesion burden and more lacunes. A severe small vessel disease phenotype compatible with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy was rarely seen. CONCLUSIONS: Cysteine altering NOTCH3 variants are an important contributor to the risk of stroke, lacunes, and white matter hyperintensities in the elderly population. Lippincott Williams & Wilkins 2020-11-09 2020-12 /pmc/articles/PMC7678653/ /pubmed/33161844 http://dx.doi.org/10.1161/STROKEAHA.120.030343 Text en © 2020 The Authors. Stroke is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial-NoDerivs (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited, the use is noncommercial, and no modifications or adaptations are made. |
spellingShingle | Original Contributions Hack, Remco J. Rutten, Julie W. Person, Thomas N. Li, Jiang Khan, Ayesha Griessenauer, Christoph J. Abedi, Vida Lesnik Oberstein, Saskia A.J. Zand, Ramin Cysteine-Altering NOTCH3 Variants Are a Risk Factor for Stroke in the Elderly Population |
title | Cysteine-Altering NOTCH3 Variants Are a Risk Factor for Stroke in the Elderly Population |
title_full | Cysteine-Altering NOTCH3 Variants Are a Risk Factor for Stroke in the Elderly Population |
title_fullStr | Cysteine-Altering NOTCH3 Variants Are a Risk Factor for Stroke in the Elderly Population |
title_full_unstemmed | Cysteine-Altering NOTCH3 Variants Are a Risk Factor for Stroke in the Elderly Population |
title_short | Cysteine-Altering NOTCH3 Variants Are a Risk Factor for Stroke in the Elderly Population |
title_sort | cysteine-altering notch3 variants are a risk factor for stroke in the elderly population |
topic | Original Contributions |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678653/ https://www.ncbi.nlm.nih.gov/pubmed/33161844 http://dx.doi.org/10.1161/STROKEAHA.120.030343 |
work_keys_str_mv | AT hackremcoj cysteinealteringnotch3variantsareariskfactorforstrokeintheelderlypopulation AT ruttenjuliew cysteinealteringnotch3variantsareariskfactorforstrokeintheelderlypopulation AT personthomasn cysteinealteringnotch3variantsareariskfactorforstrokeintheelderlypopulation AT lijiang cysteinealteringnotch3variantsareariskfactorforstrokeintheelderlypopulation AT khanayesha cysteinealteringnotch3variantsareariskfactorforstrokeintheelderlypopulation AT griessenauerchristophj cysteinealteringnotch3variantsareariskfactorforstrokeintheelderlypopulation AT abedivida cysteinealteringnotch3variantsareariskfactorforstrokeintheelderlypopulation AT lesnikobersteinsaskiaaj cysteinealteringnotch3variantsareariskfactorforstrokeintheelderlypopulation AT zandramin cysteinealteringnotch3variantsareariskfactorforstrokeintheelderlypopulation |